<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<base href="SBA%206/26/25%202R">
<title>S2019 2R</title>
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Albertus Extra Bold";
	panose-1:2 14 8 2 4 3 4 2 2 4;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
@font-face
	{font-family:AlbertusExtraBold;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:Times;
	panose-1:2 2 6 3 6 4 5 2 3 4;}
@font-face
	{font-family:Albertus;
	panose-1:0 0 0 0 0 0 0 0 0 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	background:navy;
	font-size:12.0pt;
	font-family:"Tahoma",sans-serif;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
p.FronterPage, li.FronterPage, div.FronterPage
	{mso-style-name:FronterPage;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Para10pt
	{mso-style-name:Para10pt;
	font-family:"Times New Roman",serif;}
p.PrefileFronterTitle, li.PrefileFronterTitle, div.PrefileFronterTitle
	{mso-style-name:PrefileFronterTitle;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.StylePrefileFronterTitleLeft, li.StylePrefileFronterTitleLeft, div.StylePrefileFronterTitleLeft
	{mso-style-name:"Style PrefileFronterTitle + Left";
	margin-top:0in;
	margin-right:-.2in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	font-size:17.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BillHead
	{mso-style-name:BillHead;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillHeading2
	{mso-style-name:BillHeading2;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
span.BillLanguage
	{mso-style-name:BillLanguage;
	font-family:"Times New Roman",serif;
	font-style:italic;}
p.HangingAnAct, li.HangingAnAct, div.HangingAnAct
	{mso-style-name:HangingAnAct;
	mso-style-link:"HangingAnAct Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.HangingAnActChar
	{mso-style-name:"HangingAnAct Char";
	mso-style-link:HangingAnAct;
	letter-spacing:.2pt;}
span.11ptChar
	{mso-style-name:11ptChar;
	font-family:"Times New Roman",serif;}
span.BillHeadUnBold
	{mso-style-name:BillHeadUnBold;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.bpuBill, li.bpuBill, div.bpuBill
	{mso-style-name:bpuBill;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:26.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuHeadSpon, li.bpuHeadSpon, div.bpuHeadSpon
	{mso-style-name:bpuHeadSpon;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
span.bpuHeadSponChar
	{mso-style-name:bpuHeadSponChar;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuIntro, li.bpuIntro, div.bpuIntro
	{mso-style-name:bpuIntro;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuLegislature, li.bpuLegislature, div.bpuLegislature
	{mso-style-name:bpuLegislature;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:24.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuNormText, li.bpuNormText, div.bpuNormText
	{mso-style-name:bpuNormText;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.bpuReprint, li.bpuReprint, div.bpuReprint
	{mso-style-name:bpuReprint;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:22.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.bpuSponsor, li.bpuSponsor, div.bpuSponsor
	{mso-style-name:bpuSponsor;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.bpuState, li.bpuState, div.bpuState
	{mso-style-name:bpuState;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:32.0pt;
	font-family:"Arial",sans-serif;
	font-weight:bold;}
span.charMarlett
	{mso-style-name:charMarlett;
	font-family:Marlett;}
p.ElevenPt, li.ElevenPt, div.ElevenPt
	{mso-style-name:ElevenPt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPage12pt, li.FronterPage12pt, div.FronterPage12pt
	{mso-style-name:FronterPage12pt;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageBillHeading, li.FronterPageBillHeading, div.FronterPageBillHeading
	{mso-style-name:FronterPageBillHeading;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;}
p.FronterPageNOCAPS, li.FronterPageNOCAPS, div.FronterPageNOCAPS
	{mso-style-name:FronterPageNOCAPS;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	font-size:12.0pt;
	font-family:"Times",serif;}
p.FronterPageTBox2, li.FronterPageTBox2, div.FronterPageTBox2
	{mso-style-name:FronterPageTBox2;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
p.FronterPageTextBox, li.FronterPageTextBox, div.FronterPageTextBox
	{mso-style-name:FronterPageTextBox;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.FronterSameAs, li.FronterSameAs, div.FronterSameAs
	{mso-style-name:FronterSameAs;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Pg2Footer, li.Pg2Footer, div.Pg2Footer
	{mso-style-name:Pg2Footer;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.Style10pt
	{mso-style-name:"Style 10 pt";
	font-family:"Times New Roman",serif;}
p.StyleFronterPage11pt, li.StyleFronterPage11pt, div.StyleFronterPage11pt
	{mso-style-name:"Style FronterPage + 11 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.StyleFronterPageLoweredby3pt, li.StyleFronterPageLoweredby3pt, div.StyleFronterPageLoweredby3pt
	{mso-style-name:"Style FronterPage + Lowered by  3 pt";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	position:relative;
	top:3.0pt;}
p.StyleFronterSameAsPatternSolid100White, li.StyleFronterSameAsPatternSolid100White, div.StyleFronterSameAsPatternSolid100White
	{mso-style-name:"Style FronterSameAs + Pattern\: Solid \(100%\) \(White\)";
	margin:0in;
	margin-bottom:.0001pt;
	background:white;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	text-align:justify;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
span.Whereas
	{mso-style-name:Whereas;
	font-family:"Times New Roman",serif;
	font-variant:small-caps;
	font-weight:bold;}
p.bpuWpGraphic, li.bpuWpGraphic, div.bpuWpGraphic
	{mso-style-name:bpuWpGraphic;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.LeftBrackt
	{mso-style-name:LeftBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.RightBrackt
	{mso-style-name:RightBrackt;
	font-family:"Albertus Extra Bold",sans-serif;
	font-weight:bold;}
span.Superscript
	{mso-style-name:Superscript;
	font-family:"Albertus",sans-serif;
	font-weight:bold;
	vertical-align:super;}
p.sponUdate, li.sponUdate, div.sponUdate
	{mso-style-name:sponUdate;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
span.BoldItal
	{mso-style-name:BoldItal;
	font-weight:bold;
	font-style:italic;}
p.amendfooter, li.amendfooter, div.amendfooter
	{mso-style-name:amendfooter;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	font-weight:bold;}
p.HangingSup, li.HangingSup, div.HangingSup
	{mso-style-name:HangingSup;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.2in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-.2in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableBottom, li.HangingTableBottom, div.HangingTableBottom
	{mso-style-name:HangingTableBottom;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
p.HangingTableTop, li.HangingTableTop, div.HangingTableTop
	{mso-style-name:HangingTableTop;
	margin-top:0in;
	margin-right:.5in;
	margin-bottom:0in;
	margin-left:.8in;
	margin-bottom:.0001pt;
	text-indent:-.8in;
	line-height:120%;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	letter-spacing:.2pt;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-link:"Balloon Text";
	font-family:"Segoe UI",sans-serif;
	letter-spacing:.2pt;}
.MsoChpDefault
	{font-size:10.0pt;}
 /* Page Definitions */
 @page WordSection1
	{size:8.5in 14.0in;
	margin:1.5in 1.0in 1.0in 1.0in;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 14.0in;
	margin:1.5in 113.75pt 1.0in 113.75pt;}
div.WordSection2
	{page:WordSection2;}
@page WordSection3
	{size:8.5in 14.0in;
	margin:1.0in 1.75in 1.2in 2.0in;}
div.WordSection3
	{page:WordSection3;}
-->
</style>

</head>

<body lang=EN-US>

<div class=WordSection1>

<p class=bpuReprint>[Second Reprint]</p>

<p class=bpuBill>SENATE, No. 2019 </p>

<p class=bpuWpGraphic></p>

<p class=bpuState>STATE OF NEW JERSEY</p>

<p class=bpuLegislature>221st LEGISLATURE</p>

<p class=bpuWpGraphic>  </p>

<p class=bpuIntro>PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION</p>

<p class=bpuIntro>&nbsp;</p>

</div>

<span style='font-size:12.0pt;line-height:120%;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:auto'>
</span>

<div class=WordSection2>

<p class=bpuIntro>&nbsp;</p>

<p class=bpuSponsor>Sponsored by:</p>

<p class=bpuSponsor>Senator  VIN GOPAL</p>

<p class=bpuSponsor>District 11 (Monmouth)</p>

<p class=bpuSponsor>Senator  JOHN F. MCKEON</p>

<p class=bpuSponsor>District 27 (Essex and Passaic)</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>Co-Sponsored by:</p>

<p class=bpuSponsor>Senators Turner, McKnight, Ruiz and Cruz-Perez</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>&nbsp;</p>

<p class=bpuSponsor>SYNOPSIS</p>

<p class=bpuNormText>     Authorizes pharmacists to dispense HIV prophylaxis
without individual prescription under certain circumstances; mandates
prescription benefits coverage. </p>

<p class=bpuNormText>&nbsp;</p>

<p class=bpuSponsor>CURRENT VERSION OF TEXT </p>

<p class=bpuNormText>     As reported by the Senate Budget and Appropriations
Committee on June 26, 2025, with amendments.</p>

<p class=bpuNormText>   </p>

</div>

<span style='font-size:10.0pt;font-family:"Times New Roman",serif'><br
clear=all style='page-break-before:always'>
</span>

<div class=WordSection3>

<p class=HangingAnAct style='line-height:150%'><span class=BillHead>An Act</span><span
class=HangingAnActChar> </span>concerning pharmacists and supplementing Titles
17, 26, 45, and 52 of the Revised Statutes and Title 17B of the New Jersey
Statutes.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     <span class=BillHeading2>Be It
Enacted </span><span class=BillLanguage>by the Senate and General Assembly of
the State of New Jersey:</span></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     1.    As used in this act:</p>

<p class=MsoNormal style='line-height:150%'>     CDC PEP guidelines means the
Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual,
Injection Drug Use, or Other Nonoccupational Exposure to HIV  United States,
2016, or any subsequent guidelines <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>, published by
the federal Centers for Disease Control and Prevention<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>2</sup></span></b> .</p>

<p class=MsoNormal style='line-height:150%'>     CDC <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>PReP<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>PrEP</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
guidelines means the  <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>2017<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>2</sup></span></b>
Preexposure Prophylaxis for the Prevention of HIV Infection in the United
States  <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>2017<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>2021</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b> Update:
A Clinical Practice Guideline, or any subsequent guidelines <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>, published by
the federal Centers for Disease Control and Prevention<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>2</sup></span></b> .</p>

<p class=MsoNormal style='line-height:150%'>     HIV means the human
immunodeficiency virus.</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>a fixed-dose
combination of tenofovir disoproxil fumarate (TDF) (300 mg) with emtricitabine
(FTC) (200 mg), or another<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>any</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
drug or drug combination <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>determined by
the State Board of Pharmacy to meet<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>authorized or approved by the United States Food and Drug Administration for
the prevention of HIV that meets</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>same<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>
clinical <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>eligibility<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>
recommendations <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>,
and that is furnished according to the standards of care,</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
provided in the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>CEC PReP<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>CDC PrEP</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
guidelines <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>or
any subsequent guidelines</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2
</span></sup></b>.</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>:  tenofovir
disoproxil fumarate (TDF) (300 mg) with emtricitabine (FTC) (200 mg), taken
once daily, in combination with either raltegravir (400mg), taken twice daily,
or dolutegravir (50mg), taken once daily; tenofovir disoproxil fumarate (TDF)
(300 mg) with emtricitabine (FTC) (200 mg), taken once daily, in combination
with darunavir (800mg) and ritonavir (100mg), taken once daily; or another<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>any</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> drug or
drug combination <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>determined by
the State Board of Pharmacy to meet<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>authorized or approved by the United States Food and Drug Administration</u>
<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><u>for the
prevention of HIV</u><b><span style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>2</sup></span></b>
<u>that meets</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1
</span></sup></b>the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>same<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>
clinical <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>eligibility<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>
recommendations <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>for
HIV postexposure prophylaxis</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>
<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>,
and that is furnished according to the standards of care,</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> provided
in the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>CEC PRP<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>CDC PEP</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
guidelines <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>or
any subsequent guidelines</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>
.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>Standards
of care means the care of a pharmacist ordering and providing HIV preexposure
prophylaxis or HIV postexposure prophylaxis services as determined by the circumstances
that present in practice, which care meets the same standard of care provided
by other qualified  health care professional in the same or similar setting.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b></p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     2.    a.  Notwithstanding any
other provision of law to the contrary, a pharmacist may initiate and furnish
HIV preexposure prophylaxis or HIV postexposure prophylaxis to a patient
without an individual prescription pursuant to a standing order issued to the
pharmacist by the Commissioner of Health or, if the commissioner is not a duly
licensed physician, the Deputy Commissioner for Public Health Services.  A
standing order shall be issued to a pharmacist upon request, provided that the
pharmacist satisfies the training requirements set forth in subsection b. of
this section and certifies that the pharmacist will adhere to the requirements
set forth in subsection c. of this section concerning the protocols for
initiating and furnishing HIV preexposure prophylaxis and the requirements set
forth in subsection d. of this section concerning the protocols for initiating
and furnishing HIV postexposure prophylaxis to patients without an individual
prescription.  In no case shall a patient be authorized to waive the
consultation required pursuant to subsection c. or subsection d. of this
section.</p>

<p class=MsoNormal style='line-height:150%'>     b.    A pharmacist shall not
be authorized to furnish HIV preexposure prophylaxis or HIV postexposure
prophylaxis to a patient without an individual prescription unless the
pharmacist completes a training program, <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>provided
by the Department of Health or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved by the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>State Board of
Pharmacy<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>Department of Health</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>
<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>in
consultation with the Department of Health<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>,
concerning the use of HIV preexposure prophylaxis and HIV postexposure
prophylaxis.  At a minimum, the training program shall include information about
financial assistance programs available to patients to assist with the costs of
HIV preexposure prophylaxis and HIV postexposure prophylaxis.  </p>

<p class=MsoNormal style='line-height:150%'>     c.     A pharmacist shall
furnish at least a 30-day supply, and up to a <b><sup><span style='font-family:
"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span style='font-family:
"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span style='font-family:
"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply,
of HIV preexposure prophylaxis to a patient without an individual prescription
if the following requirements are met:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   The patient is
HIV-negative, as documented by a negative HIV test result obtained within the
previous seven days from an HIV antigen/antibody test or antibody-only test or
from a rapid, point-of-care fingerstick blood test approved by the federal Food
and Drug Administration.  If the patient does not provide evidence of a
negative HIV test in accordance with this paragraph, the pharmacist shall <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>administer
an HIV test waived under the federal &quot;Clinical Laboratory Improvement
Amendments of 1988 (CLIA),&quot; Pub. L. 100-578 (42 U.S.C. s.263a) or</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> order
an HIV test.  If the test results are not ordered directly <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>to a<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>by the</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
pharmacist, the pharmacist shall verify the test results to the pharmacists
satisfaction.  If the patient tests positive for HIV infection, the pharmacist
or person administering the test shall direct the patient to a primary care
provider, provide the patient with information and resources concerning
treatment providers and HIV treatment clinics in the region, and take all other
actions required under State and federal law in response to a positive test for
HIV;</p>

<p class=MsoNormal style='line-height:150%'>     (2)   The patient does not
report any signs or symptoms of acute HIV infection on a self-reported
checklist of acute HIV infection signs and symptoms;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   The patient does not
report taking any contraindicated medications, and the pharmacist reviews <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>, to
the extent possible,</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
the patients prescription monitoring information to confirm no contraindicated
prescriptions have been issued or dispensed <b><sup><span style='font-family:
"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>by the treating
pharmacist or the pharmacy affiliated with the treating pharmacist to</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> the
patient in the past six months;</p>

<p class=MsoNormal style='line-height:150%'>     (4)   The patient has not been
furnished with HIV preexposure prophylaxis without an individual prescription
within the past two years <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>based
on the information provided by the patient to the pharmacist or the information
available in the patients records</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>;</p>

<p class=MsoNormal style='line-height:150%'>     (5)   The pharmacist provides
counseling to the patient on the ongoing use of HIV preexposure prophylaxis,
which may include education about side effects, safety during pregnancy and
breastfeeding, adherence to recommended dosing, and the importance of timely
testing and treatment, as applicable, for HIV, renal function, hepatitis B,
hepatitis C, sexually transmitted diseases, and pregnancy for individuals of
child-bearing capacity.  The pharmacist shall notify the patient that the
patient will not be eligible to continue receiving HIV preexposure prophylaxis
unless the patient is seen by a primary care provider and issued a prescription
for the HIV preexposure prophylaxis, and that the patient may be furnished with
no more than a <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
of HIV preexposure prophylaxis by a pharmacist without an individual
prescription within any given two year period;</p>

<p class=MsoNormal style='line-height:150%'>     (6)   The pharmacist
documents, to the extent possible, the services provided by the pharmacist in
the patients record in the record system maintained by the pharmacy, and
includes the dispensation of the HIV preexposure prophylaxis in the
prescription monitoring database established pursuant to P.L.2007, c.244
(C.45:1-45 et al.) with a note indicating the HIV preexposure prophylaxis was
provided without an individual prescription pursuant to this section; and</p>

<p class=MsoNormal style='line-height:150%'>     (7)   The pharmacist notifies
the patients primary care provider that the pharmacist furnished the patient
with HIV preexposure prophylaxis pursuant to this section.  If the patient does
not have a primary care provider, or refuses to consent to the pharmacist
providing notice to the primary care provider pursuant to this paragraph, the
pharmacist shall provide the patient with a list of physicians and surgeons,
clinics, or other health care service providers to contact regarding ongoing
care for HIV preexposure prophylaxis.  The Department of Health shall publish
and maintain a current list of providers for pharmacists to use for the
purposes of this paragraph, which list may be made available on the
departments Internet website.</p>

<p class=MsoNormal style='line-height:150%'>     d.    A pharmacist shall
furnish a complete course of HIV postexposure prophylaxis to a patient without
an individual prescription if the following requirements are met:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   The pharmacist confirms
with the patient that the exposure to HIV occurred within the previous 72 hours
and the patient otherwise meets the clinical criteria for HIV postexposure
prophylaxis consistent with the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>standard
of care outlined in the</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
CDC PEP guidelines <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>or
any subsequent guidelines</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>
;<span style='font-size:11.0pt;line-height:150%;font-family:"Calibri",sans-serif;
color:#1F497D'> </span></p>

<p class=MsoNormal style='line-height:150%'>     (2)   The pharmacist provides
HIV testing that is classified as waived under the federal Clinical Laboratory
Improvement Amendments of 1988, 42 U.S.C. s.263a, or determines the patient is
willing to undergo HIV testing consistent with the CDC PEP guidelines <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>or
any subsequent guidelines</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2
</span></sup></b>;</p>

<p class=MsoNormal style='line-height:150%'>     (3)   The pharmacist provides
counseling to the patient on the use of HIV postexposure prophylaxis consistent
with the <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>standard
of care outlined in the</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
CDC PEP guidelines <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>or
any subsequent guidelines</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2
</span></sup></b>, which may include education about side effects, safety
during pregnancy and breastfeeding, adherence to recommended dosing, and the
importance of timely testing and treatment, as applicable, for HIV and sexually
transmitted diseases.  The pharmacist shall additionally inform the patient of
the availability of HIV preexposure prophylaxis for persons who are at
substantial risk of acquiring HIV; and</p>

<p class=MsoNormal style='line-height:150%'>     (4)   The pharmacist notifies
the patients primary care provider that the pharmacist provided the patient
with a complete course of HIV postexposure prophylaxis.  If the patient does
not have a primary care provider, or refuses to consent to the pharmacist
providing notice to the primary care provider pursuant to this paragraph, the
pharmacist shall provide the patient with a list of physicians and surgeons,
clinics, or other health care service providers to contact regarding followup
care for HIV postexposure prophylaxis <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>.  The<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>or an
Internet web link to this information that the</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
Department of Health shall publish <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>on
the departments Internet website</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
and maintain <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>a current list
of providers<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>
for pharmacists to use for the purposes of this paragraph<b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>, which list
may be made available on the departments Internet website<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]<sup>1</sup></span></b>.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>e.</u> 
<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>(1)</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>  <u>A
pharmacist ordering or providing HIV preexposure prophylaxis or HIV
postexposure prophylaxis under this section shall be required to do so
according to the same standards of care required under the CDC PEP guidelines or
the CDC PrEP guidelines, as applicable, for a physician or other health care
professional ordering or providing the identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>(2) 
In the event that the CDC PEP guidelines or the CDC PrEP guidelines are
unavailable, the Department of Health shall implement a process for
establishing guidelines for pharmacists to order or provide HIV preexposure
prophylaxis or HIV postexposure prophylaxis under this section in accordance to
the same standards of care, as applicable, for a physician or other health care
professional ordering or providing the identical service.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b></p>

<p class=MsoNormal style='line-height:150%'>     <u>f.     <span
style='border:none windowtext 1.0pt;padding:0in'>A licensed pharmacist who, in
good faith, tests, furnishes or provides a patient care related to </span>HIV
preexposure prophylaxis and HIV postexposure prophylaxis pursuant to this
section and <span style='border:none windowtext 1.0pt;padding:0in'>based on
information provided by said patient or the patient's legal representative shall
not be subject to civil liability, criminal prosecution, disciplinary action,
or other adverse action </span>under any professional licensing statute for any
injury or damages resulting from reliance on such information.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b></p>

<p class=MsoNormal style='line-height:150%'><u><span style='text-decoration:
 none'>&nbsp;</span></u></p>

<p class=MsoNormal style='line-height:150%'>     3.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, no group or
individual hospital service corporation contract providing hospital or medical
expense benefits shall be delivered, issued, executed, or renewed in this State
or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, unless the
contract provides benefits to any subscriber or other person covered thereunder
for </span>HIV preexposure prophylaxis and HIV postexposure prophylaxis
furnished without an individual prescription pursuant to the requirements of
section 2 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved one or more therapeutic equivalents of a drug, device, or product for
the prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the contract to cover all therapeutically equivalent versions
without prior authorization or step therapy, if at least one version is covered
without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the group or individual hospital service corporation
contract to other non-physician practitioners if the reimbursement is for a
service or procedure that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered under the</u><u><span lang=EN> contract</span>
if provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A contract offered
by </u><u><span lang=EN>a group or individual hospital service corporation</span>
shall grant a licensed pharmacist receiving reimbursement under this section
the same rights of participation, plan admission, and registration as may be
granted by the </u><u><span style='letter-spacing:-.1pt'>contract</span> to a
healthcare provider, including a physician, advanced practice nurse, or
physician assistant, who is reimbursed for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>   <span
lang=EN>A contract offered by a group or individual hospital service
corporation</span> shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require a contract offered by a group or
individual hospital service corporation to provide coverage for HIV preexposure
prophylaxis or HIV postexposure prophylaxis furnished by a pharmacist at an
out-of-network pharmacy, unless the contract has an out-of-network pharmacy
benefit.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     The provisions of this section shall apply to all contracts in
which the hospital service corporation has reserved the right to change the
premium.</span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits coverage for the prophylaxis.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     4.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, n</span>o group
or individual medical service corporation contract providing hospital or
medical expense benefits shall be delivered, issued, executed, or renewed in
this State or approved for issuance or renewal in this State by the
Commissioner of Banking and Insurance, on or after the effective date of this
act, unless the contract provides benefits to any subscriber or other person
covered thereunder for HIV preexposure prophylaxis and HIV postexposure
prophylaxis furnished without an individual prescription pursuant to the
requirements of section 2 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1 </span></sup></b>approved
one or more therapeutic equivalents of a drug, device, or product for the
prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the contract to cover all therapeutically equivalent
versions without prior authorization or step therapy, if at least one version
is covered without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the group or individual medical service corporation
contract to other non-physician practitioners if the reimbursement is for a
service or procedure that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered under the</u><u><span lang=EN> contract</span>
if provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A contract offered
by </u><u><span lang=EN>a </span>group or individual medical service
corporation shall grant a licensed pharmacist receiving reimbursement under
this section the same rights of participation, plan admission, and registration
as may be granted by the </u><u><span style='letter-spacing:-.1pt'>contract</span>
to a healthcare provider, including a physician, advanced practice nurse, or
physician assistant, who is reimbursed for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>   <span
lang=EN>A contract offered by a </span>group or individual medical service
corporation shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require a <span lang=EN>contract offered
by a </span>group or individual medical service corporation to provide coverage
for HIV preexposure prophylaxis or HIV postexposure prophylaxis furnished by a
pharmacist at an out-of-network pharmacy, unless the contract has an
out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     <span
lang=EN>The provisions of this section shall apply to all contracts in which
the </span>group or individual medical service corporation<span lang=EN> has
reserved the right to change the premium.</span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits coverage for the prophylaxis.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     5.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, n</span>o group
or individual health service corporation contract providing hospital or medical
expense benefits shall be delivered, issued, executed, or renewed in this State
or approved for issuance or renewal in this State by the Commissioner of
Banking and Insurance, on or after the effective date of this act, unless the
contract provides benefits to any subscriber or other person covered thereunder
for HIV preexposure prophylaxis and HIV postexposure prophylaxis furnished
without an individual prescription pursuant to the requirements of section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved one or more therapeutic equivalents of a drug, device, or product for
the prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the contract to cover all therapeutically equivalent
versions without prior authorization or step therapy, if at least one version
is covered without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the group or individual health service corporation contract
to other non-physician practitioners if the reimbursement is for a service or
procedure that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered under the</u><u><span lang=EN> contract</span>
if provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A contract offered by
</u><u><span lang=EN>a </span>group or individual health service corporation
shall grant a licensed pharmacist receiving reimbursement under this section
the same rights of participation, plan admission, and registration as may be
granted by the </u><u><span style='letter-spacing:-.1pt'>contract</span> to a
healthcare provider, including a physician, advanced practice nurse, or
physician assistant, who is reimbursed for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1   </span></sup></b><span
lang=EN>A contract offered by a </span>group or individual health service
corporation shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require a <span lang=EN>contract offered
by a </span>health service corporation to provide coverage for HIV preexposure
prophylaxis or HIV postexposure prophylaxis furnished by a pharmacist at an
out-of-network pharmacy, unless the contract has an out-of-network pharmacy
benefit.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>The provisions of this section shall apply to all contracts
in which the health service corporation has reserved the right to change the
premium<span lang=EN>.</span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits coverage for the prophylaxis.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     6.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, no </span>individual
health insurance policy providing hospital or medical expense benefits shall be
delivered, issued, executed, or renewed in this State or approved for issuance
or renewal in this State by the Commissioner of Banking and Insurance, on or
after the effective date of this act, unless the policy provides benefits to
any named insured or other person covered thereunder for HIV preexposure
prophylaxis and HIV postexposure prophylaxis furnished without an individual
prescription pursuant to the requirements of section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has<b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved one or more therapeutic equivalents of a drug, device, or product for
the prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the policy to cover all therapeutically equivalent
versions without prior authorization or step therapy, if at least one version is
covered without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the individual health insurance policy to other
non-physician practitioners if the reimbursement is for a service or procedure
that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered under the</u><u> <span lang=EN>policy</span>
if provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A</u><u><span
lang=EN>n </span>individual health insurance policy shall grant a licensed
pharmacist receiving reimbursement under this section the same rights of
participation, plan admission, and registration as may be granted by the </u><u><span
style='letter-spacing:-.1pt'>policy</span> to a healthcare provider, including
a physician, advanced practice nurse, or physician assistant, who is reimbursed
for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1   </span></sup></b><span
lang=EN>An </span>individual health insurance policy shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1) prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require an individual health insurance
policy to provide coverage for HIV preexposure prophylaxis or HIV postexposure
prophylaxis furnished by a pharmacist at an out-of-network pharmacy, unless the
contract has an out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     The
provisions of this section shall apply to all policies in which the insurer has
reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits coverage for the prophylaxis.</p>

<p class=MsoNormal style='line-height:150%'><b><u><sup><span style='font-family:
"Albertus Extra Bold",sans-serif'><span style='text-decoration:none'>&nbsp;</span></span></sup></u></b></p>

<p class=MsoNormal style='line-height:150%'>     7.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, </span>no group
health insurance policy providing hospital or medical expense benefits shall be
delivered, issued, executed, or renewed in this State or approved for issuance
or renewal in this State by the Commissioner of Banking and Insurance, on or
after the effective date of this act, unless the policy provides benefits to
any named insured or other person covered thereunder for HIV preexposure
prophylaxis and HIV postexposure prophylaxis furnished without an individual
prescription pursuant to the requirements of section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved one or more therapeutic equivalents of a drug, device, or product for
the prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the policy to cover all therapeutically equivalent
versions without prior authorization or step therapy, if at least one version
is covered without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the group health insurance policy to other
non-physician practitioners if the reimbursement is for a service or procedure
that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered under the</u><u> <span lang=EN>policy</span>
if provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A</u><u> group
health insurance policy shall grant a licensed pharmacist receiving
reimbursement under this section the same rights of participation, plan
admission, and registration as may be granted by the </u><u><span
style='letter-spacing:-.1pt'>policy</span> to a healthcare provider, including
a physician, advanced practice nurse, or physician assistant, who is reimbursed
for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1   </span></sup></b><span
lang=EN>A </span>group health insurance policy shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require a group health insurance policy
to provide coverage for HIV preexposure prophylaxis or HIV postexposure
prophylaxis furnished by a pharmacist at an out-of-network pharmacy, unless the
contract has an out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     The
provisions of this section shall apply to all policies in which the insurer has
reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     8.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, e</span>very
individual health benefits plan that is delivered, issued, executed, or renewed
in this State pursuant to P.L.1992, c.161 (C.17B:27A-2 et seq.) or approved for
issuance or renewal in this State, on or after the effective date of this act,
shall provide benefits to any person covered thereunder for expenses incurred <span
lang=EN>for</span> HIV preexposure prophylaxis and HIV postexposure prophylaxis
furnished without an individual prescription pursuant to the requirements of
section 2 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved one or more therapeutic equivalents of a drug, device, or product for
the prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the plan to cover all therapeutically equivalent versions
without prior authorization or step therapy, if at least one version is covered
without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the individual health benefits plan to other
non-physician practitioners if the reimbursement is for a service or procedure
that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or procedure
would otherwise be covered under the</u><u> <span lang=EN>plan</span> if
provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     An</u><u> individual
health benefits plan shall grant a licensed pharmacist receiving reimbursement
under this section the same rights of participation, plan admission, and
registration as may be granted by the </u><u><span style='letter-spacing:-.1pt'>plan</span>
to a healthcare provider, including a physician, advanced practice nurse, or
physician assistant, who is reimbursed for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1  </span></sup></b><span
lang=EN>An </span>individual health benefits plan shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require an individual health benefit plan
to provide coverage for HIV preexposure prophylaxis or HIV postexposure
prophylaxis furnished by a pharmacist at an out-of-network pharmacy, unless the
contract has an out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     The
provisions of this section shall apply to all health benefit plans in which the
carrier has reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     9.    <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, </span>every
small employer health benefits plan that is delivered, issued, executed, or
renewed in this State pursuant to P.L.1992, c.162 (C.17B:27A-17 et seq.) or
approved for issuance or renewal in this State, on or after the effective date
of this act, shall provide benefits to any person covered thereunder for HIV
preexposure prophylaxis and HIV postexposure prophylaxis furnished without an
individual prescription pursuant to the requirements of section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior
authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1 </span></sup></b>approved
one or more therapeutic equivalents of a drug, device, or product for the
prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the plan to cover all therapeutically equivalent versions
without prior authorization or step therapy, if at least one version is covered
without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the small employer health benefits plan to other
non-physician practitioners if the reimbursement is for a service or procedure
that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or procedure
would otherwise be covered under the</u><u> <span lang=EN>plan</span> if
provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A</u><u> small
employer health benefits plan shall grant a licensed pharmacist receiving
reimbursement under this section the same rights of participation, plan
admission, and registration as may be granted by the </u><u><span
style='letter-spacing:-.1pt'>plan</span> to a healthcare provider, including a
physician, advanced practice nurse, or physician assistant, who is reimbursed
for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1   </span></sup></b>A
small employer health benefits plan shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require a small employer health benefit
plan to provide coverage for HIV preexposure prophylaxis or HIV postexposure
prophylaxis furnished by a pharmacist at an out-of-network pharmacy, unless the
contract has an out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     The
provisions of this section shall apply to all health benefit plans in which the
carrier has reserved the right to change the premium.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     10.  <span lang=EN>a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, </span>notwithstanding
any provision of law to the contrary, a certificate of authority to establish
and operate a health maintenance organization in this State shall not be issued
or continued by the Commissioner of Banking and Insurance on or after the
effective date of this act unless the health maintenance organization provides
health care services to any enrollee for expenses incurred <span lang=EN>for</span> 
HIV preexposure prophylaxis and HIV postexposure prophylaxis furnished without
an individual prescription pursuant to the requirements of section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior authorization
or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1 </span></sup></b>approved
one or more therapeutic equivalents of a drug, device, or product for the
prevention of HIV and AIDS, paragraph (1) of this subsection shall not be construed
to require the plan to cover all therapeutically equivalent versions without
prior authorization or step therapy, if at least one version is covered without
prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the health maintenance organization to other
non-physician practitioners if the reimbursement is for a service or procedure
that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered by the health maintenance organization if
provided by a healthcare provider, including a physician, advanced practice nurse,
or physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     A</u><u> health
maintenance organization shall grant a licensed pharmacist receiving
reimbursement under this section the same rights of participation, plan
admission, and registration as may be granted by the health maintenance
organization to a healthcare provider, including a physician, advanced practice
nurse, or physician assistant, who is reimbursed for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1   </span></sup></b><span
lang=EN>A </span>health maintenance organization shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>c.<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>e.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     Nothing
in this section shall be construed to require a health maintenance organization
to provide coverage for HIV preexposure prophylaxis or HIV postexposure
prophylaxis furnished by a pharmacist at an out-of-network pharmacy, unless the
contract has an out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'>     <b><sup><span lang=EN
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>d.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>f.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>     The
benefits shall be provided to the same extent as for any other medical
condition under the contract.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span><b><sup><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b><span lang=EN>e.</span><b><span
lang=EN style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b><span
lang=EN> </span><u>g.</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><span
lang=EN>     </span>As used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;, c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits.</p>

<p class=MsoNormal style='line-height:150%'><b><u><sup><span style='font-family:
"Albertus Extra Bold",sans-serif'><span style='text-decoration:none'>&nbsp;</span></span></sup></u></b></p>

<p class=MsoNormal style='line-height:150%'>     11.  a.  (1)  Notwithstanding
any State law or regulation to the contrary, and except as provided in
paragraph (2) of this subsection, the Department of Human Services shall ensure
that the provision of benefits for HIV preexposure prophylaxis and HIV
postexposure prophylaxis furnished without an individual prescription pursuant
to the requirements of section 2 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) to eligible persons under the
Medicaid program, established pursuant to P.L.1968, c.413 (C.30:4D-1 et seq.),
shall be provided without the imposition of any prior authorization or step
therapy requirements.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1 </span></sup></b>approved
one or more therapeutic equivalents of a drug, device, or product for the
prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the department to ensure coverage of all therapeutically
equivalent versions without prior authorization or step therapy, if at least
one version is covered without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     b.    <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>Reimbursment
issued under this section to a pharmacist shall be at a rate that is no less
than the rate provided by the Department of Human Services to other
non-physician practitioners if the reimbursement is for a service or procedure
that meets the following criteria:</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(1)   the service or
procedure is within the scope of practice of the treating pharmacist; and </u></p>

<p class=MsoNormal style='line-height:150%'>     <u>(2)   the service or
procedure would otherwise be covered by the department if provided by a
healthcare provider, including a physician, advanced practice nurse, or
physician assistant.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>c.     The Department of
Human Services shall grant a licensed pharmacist receiving reimbursement under
this section the same rights of participation, plan admission, and registration
as may be granted by the department to a healthcare provider, including a
physician, advanced practice nurse, or physician assistant, who is reimbursed
for an identical service.</u></p>

<p class=MsoNormal style='line-height:150%'>     <u>d.</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1   </span></sup></b>As
used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits coverage for the prophylaxis.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     12.  a.  (1)  </span>Except
as provided in paragraph (2) of this subsection<span lang=EN>, </span>the State
Health Benefits Commission shall provide benefits to each person covered under
the State Health Benefits Program for expenses incurred <span lang=EN>for </span>HIV
preexposure prophylaxis and HIV postexposure prophylaxis furnished without an
individual prescription pursuant to the requirements of section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) without requiring prior authorization
or step therapy.</p>

<p class=MsoNormal style='line-height:150%'>     (2)   If the federal Food and
Drug Administration has <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><u>authorized
or</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b>
approved one or more therapeutic equivalents of a drug, device, or product for
the prevention of HIV and AIDS, paragraph (1) of this subsection shall not be
construed to require the contract to cover all therapeutically equivalent
versions without prior authorization or step therapy, if at least one version
is covered without prior authorization or step therapy.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     b.    T</span>he
State Health Benefits Commission shall not:</p>

<p class=MsoNormal style='line-height:150%'>     (1)   prohibit, or permit a
delegated pharmacy benefits manager to prohibit, a pharmacist from dispensing
HIV preexposure prophylaxis or HIV postexposure prophylaxis; and</p>

<p class=MsoNormal style='line-height:150%'>     (2)   be required to cover HIV
preexposure prophylaxis that has been furnished by a pharmacist without an
individual prescription pursuant to pursuant to section 2 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill) in excess of a <b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>60-day<b><span
style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b> <u>90-day</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>1</span></sup></b> supply
for a single patient within a given two year period.</p>

<p class=MsoNormal style='line-height:150%'>     c.     Nothing in this section
shall be construed to require the State Health Benefits Commission to provide
coverage for HIV preexposure prophylaxis or HIV postexposure prophylaxis
furnished by a pharmacist at an out-of-network pharmacy, unless the contract
has an out-of-network pharmacy benefit.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     d.    </span>The
benefits shall be provided to the same extent as for any other medical
condition under the contract.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     e.     </span>As
used in this section:</p>

<p class=MsoNormal style='line-height:150%'>     HIV preexposure prophylaxis
means the same as that term is defined in section 1 of P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     HIV postexposure prophylaxis
means the same as that term is defined in section 1 of
P.L.&nbsp;&nbsp;&nbsp;&nbsp;,
c.&nbsp;&nbsp;&nbsp;&nbsp;(C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;)
(pending before the Legislature as this bill).</p>

<p class=MsoNormal style='line-height:150%'>     Step therapy means requiring
that a lower-cost alternative to HIV preexposure prophylaxis or HIV
postexposure prophylaxis be shown to have been ineffective as a condition of
providing prescription benefits.</p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>&nbsp;</span></p>

<p class=MsoNormal style='line-height:150%'><span lang=EN>     </span>13.  The
Commissioner of Human Services shall apply for such State plan amendments or
waivers as may be necessary to implement the provisions of section 11 of this
act and to secure federal financial participation for State Medicaid
expenditures under the federal Medicaid program.</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     14.  a.  Within 90 days after
the date of enactment of this act, and notwithstanding the provisions of the
Administrative Procedure Act, P.L.1968, c.410 (C.52:14B-1 et seq.) to the
contrary, the State Board of Pharmacy <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><b><span
style='font-family:"Albertus Extra Bold",sans-serif'>[</span></b>, in
consultation with<b><span style='font-family:"Albertus Extra Bold",sans-serif'>]</span></b>
<u>and</u><b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b>
the Department of Health, immediately upon filing proper notice with the Office
of Administrative Law, shall <b><sup><span style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b><u>each</u><b><sup><span
style='font-family:"Albertus Extra Bold",sans-serif'>2</span></sup></b> adopt
rules and regulations as may be necessary to implement the provisions of this
act.</p>

<p class=MsoNormal style='line-height:150%'>     b.    The rules and
regulations adopted pursuant to subsection a. of this section shall be in
effect for a period not to exceed one year from the date of filing.  These
rules and regulations shall thereafter be adopted, amended, or readopted by the
board, in consultation with the Department of Health, in accordance with the
requirements of the Administrative Procedure Act, P.L.1968, c.410 <br>
(C.52:14B-1 et seq.).</p>

<p class=MsoNormal style='line-height:150%'>&nbsp;</p>

<p class=MsoNormal style='line-height:150%'>     15.  This act shall take
effect immediately.</p>

</div>

</body>

</html>
